Aptorum Group Ltd-Class A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.81

+0.07 (+9.06%)

As of Feb 8, 2:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,434.4% upside

Low Target $9.33

Average Target $12.39

High Target $15.15

Current Price $0.81

Current
$0.81

Target
$12.39

$9.33 $12.39 avg $15.15

Scenario Analysis

Bear Case

$9.33

1,055.4%

Low target

Base Case

$12.39

+1,434.4%

Avg target

Bull Case

$15.15

+1,776.2%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$12.00

-93.3% from high

52-Week Low

$6.44

+-87.5% from low

Target vs 52W High

$12.39

+3.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%